Statements, 2009

Goldman Sachs research paper, entitled "Health Buys Wealth", shows cost-benefits of investing in health.
 

GAVI Board Chair Mary Robinson, Melinda Gates, co-chair of the Bill & Melinda Gates Foundation, Dr Margaret Chan, Director--General, WHO, Her Royal Highness Princess Cristina of Spain and GAVI CEO Julian Lob-Levyt speak at the opening plenary session of Fourth GAVI Alliance Partners' Forum.
 

The GAVI Alliance Board today appointed Dr Jaime Sepulveda, Director of the Integrated Health Solutions Development programme at the Bill & Melinda Gates Foundation, as its new Vice-Chair.

Statement by Julian Lob-Levyt, Chief Executive Officer of the GAVI Alliance, on the release of the WHO report “Women and health: today’s evidence, tomorrow’s agenda”.
 

GAVI applauds UNICEF and WHO for sounding the alarm about a deadly yet neglected scourge with today’s publication of a new joint report, ‘Diarrhoea: Why Children Are Still Dying and What Can Be Done’.

For this year's European Development Days (Stockholm, 22-24 October), GAVI, together with Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria, UNAIDS, the Stop AIDS Alliance, and AIDS Accountability International, will organise a debate entitled: “Can the Health MDGs still be met in times of crisis?”
 

The AMC Secretariat is pleased to announce that four suppliers have made offers to supply vaccines under the Pneumococcal Advance Market Commitment.

This new report shows the impressive progress in immunisation that has been achieved over the last decade, in great part thanks to the GAVI Alliance, which includes among its members WHO, UNICEF, the World Bank, and the Gates Foundation, as well as donor and developing country governments, private industry and civil society.
 

GAVI welcomes a series of new financing measures for global health worth upto US$5.3 billion which will save the lives of millions of women and children in developing countries.
 

The GAVI Alliance congratulates its partner organisation PATH for being awarded this year’s Conrad N. Hilton Humanitarian Prize, one of the world’s most renowned humanitarian awards.
 

On the eve of the G20 meeting in London on April 2, 2009, Dr Julian Lob-Levyt, Chief Executive Officer of the GAVI Alliance, and Professor Michel Kazatchkine, Executive Director of The Global Fund, wrote an open letter inviting G20 leaders to increase investments in improving healthcare for the world's poor despite the global economic crisis.
 

President Barack Obama names Chair of GAVI's Executive Board as recipient of top American civilian honour.
 

In a landmark annual status report, leading global health players and donor nations warn that the ongoing economic crisis must not threaten international commitments to reaching the Health Millennium Development Goals (MDGs).
 

With its focus on neglected diseases and health system strengthening, President Barack Obama's global health initiative represents an important first step for the new Administration, says CEO Julian Lob-Levyt.

GAVI Alliance Chief Executive Officer Dr. Julian Lob-Levyt welcomes the April 3rd decision by the World Bank to provide a financial platform for the Alliance’s Advance Market Commitment (AMC).

GAVI Alliance Chief Executive Officer Dr Julian Lob-Levyt thanks the United States government for a US$ 75 million contribution – its highest ever -- to support the Alliance’s work to immunise children and strengthen health systems in the world’s poorest countries.

During the course of 2008, the GAVI Alliance undertook an assessment of ISS, which culminated in the establishment of an independent task team to review the quality of data and the resulting estimates of coverage that this performance-based programme relies upon. Upon completion of its final meeting in February, the task team produced a series of recommendations for GAVI.
 

Over the course of this month, GAVI’s country support team has worked with colleagues from the World Health Organization to assess and compare country-reported administrative data and WHO/UNICEF coverage estimates in the ISS programme. Our analysis shows a significantly different picture than the one presented in a study by the Institute for Health Metrics and Evaluation (IHME) issued in December.